|
1
|
Moeller BJ and Dewhirst MW: HIF-1 and
tumour radiosensitivity. Br J Cancer. 95:1–5. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ogawa Y, Nishioka A, Hamada N, Terashima
M, Inomata T, Yoshida S, Seguchi H and Kishimoto S:
Immunohistochemical study of c-fos-positive lymphocytes infiltrated
into human squamous cell carcinomas of the head and neck during
radiation therapy and its clinical significance. Clin Cancer Res.
3((12 Pt 1)): 2301–2307. 1997.PubMed/NCBI
|
|
3
|
Ogawa Y, Nishioka A, Hamada N, Terashima
M, Inomata T, Yoshida S, Seguchi H and Kishimoto S: Expression of
Fas (CDcd95/APO-1) antigen induced by radiation therapy for diffuse
B-cell lymphoma: Immunohistochemical study. Clin Cancer Res. 3((12
Pt 1)): 2211–2216. 1997.PubMed/NCBI
|
|
4
|
Ogawa Y, Kubota K, Ue H and Nishioka A:
Development and clinical application of a new radiosensitizer
containing hydrogen peroxide and hyaluronic acid sodium for topical
tumor injection-A new enzyme-targeting radiosensitization
treatment, KORTUC II (Kochi Oxydol-Radiation Therapy for
Unresectable Carcinomas, Type II). Procedings of the 8th
International Meeting on Progress in Radio-Oncology (ICRO/OGRO 8).
ICRO/OGRO 8. 183:100–101. 2007.PubMed/NCBI
|
|
5
|
Ogawa Y, Ue H, Tsuzuki K, Tadokoro M,
Miyatake K, Sasaki T, Yokota N, Hamada N, Kariya S, Hitomi J, et
al: New radiosensitization treatment (KORTUC I) using hydrogen
peroxide solution soaked gauze bolus for unresectable and
superficially exposed neoplasms. Oncol Rep. 19:1389–1394.
2008.PubMed/NCBI
|
|
6
|
Ogawa Y, Kubota K, Ue H, Kataoka Y,
Tadokoro M, Miyatake K, Tsuzuki K, Yamanishi T, Itoh S, Hitomi J,
et al: Phase I study of a new radiosensitizer containing hydrogen
peroxide and sodium hyaluronate for topical tumor injection: A new
enzyme targeting radiosensitization treatment, Kochi Oxydol
Radiation Therapy for Unresectable Carcinomas, type II (KORTUC II).
Int J Oncol. 34:609–618. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ogawa Y, Kubota K, Aoyama N, Yamanishi T,
Kariya S, Hamada N, Nogami M, Nishioka A, Onogawa M and Miyamura M:
Non-surgical breast-conserving treatment (KORTUC-BCT) using a new
radio-sensitization method (KORTUC II) for patients with stage I or
II breast cancer. Cancers (Basel). 7:2277–2289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takaoka T, Shibamoto Y, Matsuo M, Sugie C,
Murai T, Ogawa Y, Miyakawa A, Manabe Y, Kondo T, Nakajima K, et al:
Biological effects of hydrogen peroxide administered intratumorally
with or without irradiation in murine tumors. Cancer Sci.
108:1787–1792. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shimbo T, Nakata M, Yoshioka H, Sato C,
Hori A, Kimura K, Iwamoto M, Yoshida K, Uesugi Y, Akiyama H and
Nihei K: New enzyme-targeting radiosensitizer (KORTUC II) treatment
for locally advanced or recurrent breast cancer. Mol Clin Oncol.
15:2412021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Obata S, Ishimaru Y, Miyagi S, Nakatake M,
Kuroiwa A, Ohta Y, Kan T, Kanegae S, Inoue Y, Nishizato R and
Miyazaki K: Actual practice of Kochi oxydol radiation therapy for
unresectable carcinomas by intra-tumoral administration of hydrogen
peroxide as a radiosensitizer. Mol Clin Oncol. 16:682022.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nishioka A, Ogawa Y, Miyatake K, Tadokoro
M, Nogami M, Hamada N, Kubota K, Kariya S, Kohsaki T, Saibara T, et
al: Safety and efficacy of image-guided enzyme-targeting
radiosensitization and intraoperative radiotherapy for locally
advanced unresectable pancreatic cancer. Oncol Lett. 8:404–408.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tseng M, Ngoi NY, Tan DS and Tong PS:
Combined modality management of advanced cervical cancer including
novel sensitizers. Int J Gynecol Cancer. 32:246–259. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou Y, Espenel S, Achkar S, Leary A, Gouy
S and Chargari C: Combined modality including novel sensitizers in
gynecological cancers. Int J Gynecol Cancer. 32:389–401. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakata M, Yoshida K, Shimbo T, Yoshikawa
N, Yoshioka H, Hori A, Sato C, Uesugi Y, Kogata Y, Masui K, et al:
High-dose-rate interstitial brachytherapy with hypoxic
radiosensitizer KORTUC II for unresectable pelvic sidewall
recurrence of uterine cervical cancer: A case report. J Contemp
Brachytherapy. 12:606–611. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miller B, Morris M, Rutledge F, Mitchell
MF, Atkinson EN, Burke TW and Wharton JT: Aborted exenterative
procedures in recurrent cervical cancer. Gynecol Oncol. 50:94–99.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maneo A, Landoni F, Cormio G, Colombo A,
Placa F, Pellegrino A and Mangioni C: Concurrent
carboplatin/5-fluorouracil and radiotherapy for recurrent cervical
carcinoma. Ann Oncol. 10:803–807. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stock RG, Chan K, Terk M, Dewyngaert JK,
Stone NN and Dottino P: A new technique for performing Syed-Neblett
template interstitial implants for gynecologic malignancies using
transrectal-ultrasound guidance. Int J Radiat Oncol Biol Phys.
37:819–825. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mabuchi S, Takahashi R, Isohashi F, Yokoi
T, Okazawa M, Sasano T, Maruoka S, Anzai M, Yoshioka Y, Ogawa K and
Kimura T: Reirradiation using highdose-rate interstitial
brachytherapy for locally recurrent cervical cancer. Int J Gynecol
Cancer. 24:141–148. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nag S, Yacoub S, Copeland LJ and Fowler
JM: Interstitial brachytherapy for salvage treatment of vaginal
recurrences in previously unirradiated endometrial cancer patients.
Int J Radiat Oncol Biol Phys. 54:1153–1159. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hedman M, Bjork-Eriksson T, Mercke C, West
C, Hesselius P and Brodin O: Comparison of predicted and clinical
response to radiotherapy: A radiobiology modelling study. Acta
Oncol. 48:584–590. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoshida K, Yamazaki H, Kotsuma T, Takenaka
T, Masui K, Yoshioka Y, Uesugi Y, Shimbo T, Yoshikawa N, Yoshioka
H, et al: Treatment results of image-guided high-dose-rate
interstitial brachytherapy for pelvic recurrence of uterine cancer.
Brachytherapy. 14:440–448. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Viswanathan AN, Cormack R, Holloway CL,
Tanaka C, O'Farrell D, Devlin PM and Tempany C: Magnetic
resonance-guided interstitial therapy for vaginal recurrence of
endometrial cancer. Int J Radiat Oncol Biol Phys. 66:91–99. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Beriwal S, Rwigema JC, Higgins E, Kim H,
Houser C, Sukumvanich P, Olawaiye A, Richard S, Kelley JL, Edwards
RP and Krivak TC: Three-dimensional imagebased high-dose-rate
interstitial brachytherapy for vaginal cancer. Brachytherapy.
11:176–180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Popowski Y, Hiltbrand E, Joliat D and
Rouzaud M: Open magnetic resonance imaging using titanium-zirconium
needles: Improved accuracy for interstitial brachytherapy implants?
Int J Radiat Oncol Biol Phys. 47:759–765. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tewari K, Cappuccini F, Brewster WR,
DiSaia PJ, Berman ML, Manetta A, Puthawala A, Nisar Syed AM and
Kohler MF: Interstitial brachytherapy for vaginal recurrences of
endometrial carcinoma. Gynecol Oncol. 74:416–422. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ogawa Y, Kubota K, Ue H, Tadokoro M,
Matsui R, Yamanishi T, Hamada N, Kariya S, Nishioka A, Nakajima H,
et al: Safety and effectiveness of a new enzyme-targeting
radio-sensitization treatment (KORTUC II) for intratumoral
injection for low-LET radio-resistant tumors. Int J Oncol.
39:553–560. 2011.PubMed/NCBI
|
|
28
|
Nimalasena S, Gothard L, Anbalagan S,
Allen S, Sinnett V, Mohammed K, Kothari G, Musallam A, Lucy C, Yu
S, et al: Intratumoral hydrogen peroxide with radiation therapy in
locally advanced breast cancer: Results from a phase 1 clinical
trial. Int J Rad Oncol Biol Phys. 108:1019–1029. 2020. View Article : Google Scholar : PubMed/NCBI
|
